Restatement of Previously Issued Financial Statements (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Restatement of Previously Issued Financial Statements (Textual)
Common stock, par value	$ 0.025		$ 0.025
Common stock, shares authorized	75,000,000		75,000,000
Common stock, shares issued	2,148,080		1,832,372
Common stock, shares outstanding	2,141,393		1,830,969
Treasury stock, shares	11,500		11,500
Proceeds from issuance of series F preferred stock, net of placement fees	$ 248,000
Description of previously issued financial statements	The impact of this adjustment by itself was an increase to APIC of $4.2MM  for the three months ending March 31, 2018 and a reduction of earnings of $4.2MM. Additionally, the Company issued public warrants in June 2017. Since the ability to issue these shares is deemed to be "out of the Company's control" to make sure there are sufficient shares available for issuance, combined with the fact that there is not specific language in the warrant documents that preclude the Company from having to issue cash if liquid shares cannot be delivered to the holder, it is deemed that a liability needs to be set up for these warrants in accordance with ASC 815 Accounting for Derivative Liabilities. Specifically, per 815-40-25-11, the events or actions necessary to deliver registered shares are not controlled by an entity and, therefore, except under the circumstances described in paragraph 815-40-25-16, if the contract permits the entity to net share or physically settle the contract only by delivering registered shares, it is assumed that the entity will be required to net cash settle the contract. As a result, the contracts are classified as a liability in our financial statements and adjusted quarterly based the change in stock value. The cumulative effect of these restatements, combined with other immaterial adjustments was an increase in liabilities of $288,824, an increase in Preferred E stock of $19,631, an increase in APIC of $4,085,247, a decrease of common stock of $159,507, and a decrease in the fair value of derivative liabilities of $4,234,195, which increased the loss on change in fair value of derivatives and other fair value liabilities in the statement of operations.
Series E Preferred Stock [Member]
Restatement of Previously Issued Financial Statements (Textual)
Preferred stock, stated value	$ 100		$ 100
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock, shares authorized	300,000		300,000
Preferred stock, shares issued	223,950		300,000
Preferred stock, shares outstanding	223,950		300,000